Translational Neuropsychiatry through Neuromodulation Lab

Clinical Trials
LIFU AUD projected to begin enrollment soon.
Learn more
Weill Institute for Neurosciences
TN2 lab is based out of Mission Bay in the Weill Institute for Neurosciences.
Learn More
Department of Neurology
TN2 Lab is within UCSF Department of Neurology which is an exceptional environment for interdisciplinary and cutting edge research and clinical care.
Learn More

Lab Overview

 

The goals of the Translational Neuropsychiatry Through Neuromodulation (TN²) Lab are to:

  • Advance our understanding and treatment of substance use and neuropsychiatric disorders
  • Adhere to principles of scientific rigor and scientific excellence
  • Provide individualized mentorship plans to meet the individual members’ career goals
  • Offer a safe and friendly environment that fosters teamwork and allows every member to grow and fulfill their potential.

The TN² lab investigates the neurobiology of substance use disorders and uses neuromodulation tools such as Low-Intensity Focused Ultrasound (LIFU), Transcranial Magnetic Stimulation (TMS), and Deep Brain Stimulation (DBS) to treat drug and alcohol addiction and related neuropsychiatric disorders. The goal of the lab is to identify neural biomarkers of craving and drug-seeking behaviors and leverage those findings to develop individualized clinical treatments with neuromodulation.

Clinical Trials

 

Alcohol Use Disorder

LIFU AUD Study

Ultrasound neuromodulation of the brain for Alcohol Use Disorder (AUD). Now enrolling.

 

LEARN MORE

Healthy Volunteers

SOMA Study

Ultrasound Neuromodulation of the brain to map LIFU parameter space. Now enrolling.

 

LEARN MORE